Editas Medicine (EDIT) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to $8.1 million.
- Editas Medicine's Receivables - Net rose 635238.1% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 635238.1%. This contributed to the annual value of $16.3 million for FY2024, which is 5967.41% up from last year.
- Per Editas Medicine's latest filing, its Receivables - Net stood at $8.1 million for Q3 2025, which was up 635238.1% from $588000.0 recorded in Q2 2025.
- Editas Medicine's 5-year Receivables - Net high stood at $16.3 million for Q4 2024, and its period low was $120000.0 during Q3 2022.
- Its 5-year average for Receivables - Net is $2.6 million, with a median of $588000.0 in 2025.
- As far as peak fluctuations go, Editas Medicine's Receivables - Net crashed by 9558.53% in 2021, and later soared by 635238.1% in 2025.
- Over the past 5 years, Editas Medicine's Receivables - Net (Quarter) stood at $267000.0 in 2021, then surged by 1826.97% to $5.1 million in 2022, then skyrocketed by 98.0% to $10.2 million in 2023, then surged by 59.67% to $16.3 million in 2024, then tumbled by 50.02% to $8.1 million in 2025.
- Its last three reported values are $8.1 million in Q3 2025, $588000.0 for Q2 2025, and $510000.0 during Q1 2025.